Physician profile
Jeremy Doak
NPI 1003071234
$4,132.91
in general payments reported to CMS, 2019-2025
8 companies · $201 in 2025
The $201 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $159 · 2021: $1,561 · 2022: $396 · 2023: $517 · 2024: $1,140 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $937 · Travel and Lodging: $921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $936.81 |
| Travel and Lodging | $920.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,705.99 | 2019-2025 | Q-Fix, Evos, Microraptor |
| Prodigy Surgical Distribution, INC. | $1,222.94 | 2021-2023 | |
| Medtronic, INC. | $54.23 | 2021 | |
| Stryker Corporation | $45.98 | 2025 | Surpass Evolve |
| Vb Spine LLC | $37.51 | 2025 | Mesa Spinal System |
| Globus Medical, INC. | $25.24 | 2023 | Excelsiusgps Robotic Navigation System |
| Abbvie INC. | $21.96 | 2023 | Botox |
| Boston Scientific Corporation | $19.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremy Doak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.